These results were a surprise to us because they seemed to be less additive or synergistic than expected, and different from what other studies had reported.30, 31, 32 It is well known that PPARα activation in the liver reduces hepatic steatosis by increasing the lipid oxidation. The gene discussed is PPARA; the disease is fatty liver disease.